Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids 2–4 April 2004, Naarden, The Netherlands
- 1 September 2004
- journal article
- congress
- Published by Elsevier in Neuromuscular Disorders
- Vol. 14 (8-9) , 526-534
- https://doi.org/10.1016/j.nmd.2004.05.006
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Bone mineral density and bone metabolism in Duchenne muscular dystrophyOsteoporosis International, 2003
- Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naive patients with acute mania: a double blind and placebo controlled trialBMC Psychiatry, 2003
- Vertebral Fractures in Boys with Duchenne Muscular DystrophyClinical Pediatrics, 2003
- 107th ENMC International Workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th–9th June 2002, Naarden, the NetherlandsNeuromuscular Disorders, 2003
- Physical capacity in non‐ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal studyDevelopmental Medicine and Child Neurology, 2002
- Vertebral compression in Duchenne muscular dystrophy following deflazacortNeuromuscular Disorders, 2002
- Deflazacort in Duchenne dystrophy: Study of long‐term effectMuscle & Nerve, 1994
- Prednisone in Duchenne DystrophyArchives of Neurology, 1991
- Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular DystrophyNew England Journal of Medicine, 1989
- Quantitation of muscle function in children: A prospective study in duchenne muscular dystrophyMuscle & Nerve, 1982